ATE145243T1 - Antibiotikum-reuterin - Google Patents

Antibiotikum-reuterin

Info

Publication number
ATE145243T1
ATE145243T1 AT88904356T AT88904356T ATE145243T1 AT E145243 T1 ATE145243 T1 AT E145243T1 AT 88904356 T AT88904356 T AT 88904356T AT 88904356 T AT88904356 T AT 88904356T AT E145243 T1 ATE145243 T1 AT E145243T1
Authority
AT
Austria
Prior art keywords
reuterin
antibiotic
effective
prodn
glycerol
Prior art date
Application number
AT88904356T
Other languages
English (en)
Inventor
Walter J Dobrogosz
Sven E Lindgren
Original Assignee
Biogaia Biolog Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Biolog Ab filed Critical Biogaia Biolog Ab
Application granted granted Critical
Publication of ATE145243T1 publication Critical patent/ATE145243T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88904356T 1987-05-01 1988-04-28 Antibiotikum-reuterin ATE145243T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4602787A 1987-05-01 1987-05-01
US10283087A 1987-09-22 1987-09-22

Publications (1)

Publication Number Publication Date
ATE145243T1 true ATE145243T1 (de) 1996-11-15

Family

ID=26723487

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88904356T ATE145243T1 (de) 1987-05-01 1988-04-28 Antibiotikum-reuterin
AT95112754T ATE332649T1 (de) 1987-05-01 1988-04-28 Reuterin enthaltende nährungszusammensetzung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT95112754T ATE332649T1 (de) 1987-05-01 1988-04-28 Reuterin enthaltende nährungszusammensetzung

Country Status (10)

Country Link
EP (2) EP0357673B1 (de)
JP (2) JP3007092B2 (de)
AT (2) ATE145243T1 (de)
AU (1) AU620807B2 (de)
CA (1) CA1314255C (de)
DE (2) DE3855664T2 (de)
DK (1) DK174229B1 (de)
FI (2) FI895197A0 (de)
NO (2) NO301430B1 (de)
WO (1) WO1988008452A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198425A (en) * 1989-08-30 1993-03-30 Bio-Mega, Inc. Inhibitors of bacterial ribonucleotide reductase
ATE216250T1 (de) * 1991-01-28 2002-05-15 Biogaia Ab Verfahren zur verabreichung des fertigfutter- mikroorganismus lactobacillus reuteri an vögel in ovo
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
GB9803424D0 (en) * 1998-02-18 1998-04-15 Pfizer Ltd Performance enhancement
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
EP1885383B1 (de) 2005-05-31 2016-09-21 IAMS Europe B.V. Katzen probiotisches bifidobacterium
EP2124966B1 (de) 2007-02-01 2015-09-09 IAMS Europe B.V. Verfahren zur verringerung von entzündung und oxidativem stress bei einem säugetier mit glucose-antimetaboliten, avocado oder avocado-extrakten
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8617537B2 (en) * 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
EP2158813A1 (de) 2008-08-28 2010-03-03 Omya Development AG Stabilisierung von wässrigen Mineralpräparaten durch Reuterin
US20100160224A1 (en) * 2008-10-14 2010-06-24 David Thomas Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2013079992A1 (en) * 2011-11-30 2013-06-06 Compagnie Gervais Danone Reuterin-producing lactobacillus brevis
EP2838365A4 (de) * 2012-04-16 2016-04-13 Cascades Canada Ulc Antimikrobielle zusammensetzungen und verwendungen davon
EP2674162A1 (de) * 2012-05-29 2013-12-18 Danuta Kruszewska Nanoprodukt, beinhaltend lactobacillus reuteri dan080, zur verwendung bei der prophylaxe, diagnose sowie bei der medizinischen and veterinärmedizinischen behandlung
KR20150027152A (ko) * 2012-05-29 2015-03-11 다누타 크루셰프스카 인간 및 동물 모두에서 예방 및 의약에 유용한 락토바실러스 류테리 ｄａｎ080을 포함하는 나노프로덕트 및 이의 의학적 용도
US9861666B2 (en) 2013-08-12 2018-01-09 Mansel Griffiths Antiviral methods and compositions comprising probiotic bacterial molecules
ITUB20152987A1 (it) * 2015-08-07 2017-02-07 Minaba Tech S R L Procedimento di bio-conservazione di prodotti ittici e relativi prodotti
CN105340974B (zh) * 2015-10-30 2018-01-09 湖北省生物农药工程研究中心 一种生物拌种剂及应用
WO2022140401A1 (en) 2020-12-23 2022-06-30 Church & Dwight Co., Inc. Lactobacillus compositions and methods for prevention and treatment of microbial infection
CN114806929B (zh) * 2022-03-29 2023-10-31 山东凤凰生物科技股份有限公司 一株高产罗伊氏菌素的罗伊氏乳杆菌lr4009及其应用
US20250320401A1 (en) 2024-04-12 2025-10-16 Schlumberger Technology Corporation Corrosion inhibitor and related methods of inhibiting the corrosion of metal surfaces

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687981A (en) * 1968-01-17 1972-08-29 Du Pont Process for making a dioxane
US4053638A (en) * 1970-05-06 1977-10-11 William Wrigley Jr. Company Anticaries confectioneries and oral health products
JPS60116369U (ja) 1984-01-11 1985-08-06 リョービ株式会社 ゴルフクラブメタルヘツド
US10283087B2 (en) 2016-06-15 2019-05-07 Sk Planet Co., Ltd. Digital signage device and method for operating the same

Also Published As

Publication number Publication date
EP0357673A1 (de) 1990-03-14
DE3855664T2 (de) 1997-03-20
ATE332649T1 (de) 2006-08-15
FI110366B (fi) 2002-12-31
JP3244659B2 (ja) 2002-01-07
NO963930L (no) 1989-02-28
NO308982B1 (no) 2000-11-27
FI960543L (fi) 1996-02-06
NO885833D0 (no) 1988-12-30
WO1988008452A1 (en) 1988-11-03
EP0698347A3 (de) 1999-09-08
JPH11137292A (ja) 1999-05-25
JPH02503385A (ja) 1990-10-18
FI895197A7 (fi) 1989-11-01
DK542889D0 (da) 1989-10-31
NO963930D0 (no) 1996-09-19
FI895197A0 (fi) 1989-11-01
AU620807B2 (en) 1992-02-27
EP0698347A2 (de) 1996-02-28
DK174229B1 (da) 2002-10-07
EP0357673B1 (de) 1996-11-13
EP0357673A4 (en) 1991-09-25
EP0698347B1 (de) 2006-07-12
DE3855664D1 (de) 1996-12-19
DE3856591D1 (de) 2006-08-24
NO301430B1 (no) 1997-10-27
DK542889A (da) 1989-10-31
FI960543A0 (fi) 1996-02-06
CA1314255C (en) 1993-03-09
JP3007092B2 (ja) 2000-02-07
NO885833L (no) 1989-02-28
AU1724588A (en) 1988-12-02

Similar Documents

Publication Publication Date Title
ATE145243T1 (de) Antibiotikum-reuterin
McDonald et al. Enhanced recovery of injured Escherichia coli by compounds that degrade hydrogen peroxide or block its formation
Krumholz et al. Eubacterium oxidoreducens sp. nov. requiring H2 or formate to degrade gallate, pyrogallol, phloroglucinol and quercetin
KR890002391A (ko) 산성 우레아제 및 그의 제조방법
FR2187301A1 (en) Alpha-6-deoxy-5-hydroxy tetracycline - by microbiological transformation of anhydro-5-hydroxy tetracycline
Daron Occurrence of isocitrate lyase in a thermophilic Bacillus species
ES2051890T3 (es) Procedimiento para aislar la enzima carnitinhidroliasa de cepas pertenecientes a la familia enterobacteriaceae y empleo de la enzima inmobilizada para producir l(-)-carnitina.
JPS52128293A (en) Preparation of 7-aminocephalosporanic acid and its derivatives
Phillips et al. A novel inhibitor of NADH dehydrogenase in Paracoccus denitrificans.
Smith et al. The utilization of some halogenated aromatic acids by Nocardia. Effects on the growth and enzyme induction
SE7612293L (sv) Antibiotikum
Nisman et al. Diphosphopyridine nucleotide and phosphate requirement for oxidation of amino-acids by cell-free extracts of obligate anaerobes
Imai Transport system for citric acid in Proteus vulgaris
WO1999041614A3 (en) Method for detecting intimin producing microorganisms
MX9204902A (es) Procedimiento microbiologico para la preparacion de acido 6-hidroxipirazincarboxilico.
JPS5736981A (en) Solution composition of liquefied spirulina and its preparation
De Repentigny et al. Inhibition by adenine of Staphylococcus aureus growth in a nutrient medium free from guanine, guanosine, or hypoxanthine
Drozdov-Tikhomirov et al. The optimal structure of the tricarboxylic acid cycle multienzyme system of E. coli for the cases of cell growth on various carbon sources
SU1294823A1 (ru) Штамм молочнокислых бактерий @ @ @ @ ВКПМ В-2430,используемый дл восстановлени нитритов мелассы
Cao et al. Quantification of Adherence of Pseudomonas aeruginosa to Chick Skins 1. Establishment of an Adherent Model
Anuradha et al. Role of sewage bacteria in methemoglobin formation in Cyprinus carpio exposed to nitrate
Jirešová et al. The effect of glucose on cellobiose uptake and β-D-glucosidase activity in Streptomyces granaticolor
JPS5747488A (en) Improved method of producing antibiotic
JPS5495795A (en) Production of interferon
Andreasen et al. INFLUENCE OF CARBON‐DIOXIDE TENSION AND MEDIUM BUFFER CONCENTRATION ON MEDIUM pH AND MIC VALUES OF ERYTHROMYCIN FOR ESCHERICHIA COLI ATCC 25922 AND STAPHYLOCOCCUS AUREUS ATCC 25923 IN A MICRO‐AEROBIC ATMOSPHERE

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time